Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lavine

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Once yearly cell-based therapy for sustained and dose tunable delivery of monoclonal antibodiesCody Fell, Anthony E Davis, Shalini Pandey, et al.
Virology|December 3, 2014
Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopesMohammed Asmal, Corinne Luedemann, Christy L Lavine, et al.
Nature Immunology|February 3, 2026
Rapid elicitation of neutralizing Asn332-glycan-independent antibodies to the V3-glycan epitope of HIV-1 Env in nonhuman primatesIgnacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, et al.
JCI Insight|October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variantMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spikePei Tong, Avneesh Gautam, Ian Windsor, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody ResponsesMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Cell|November 10, 2020
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody ProductionYuezhou Chen, Adam Zuiani, Stephanie Fischinger, et al.
Science (New York, N.Y.)|July 4, 2015
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeysDan H Barouch, Galit Alter, Thomas Broge, et al.
Cell|August 1, 2021
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spikePei Tong, Avneesh Gautam, Ian W Windsor, et al.
Cell Host & Microbe|January 11, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine DesignChristine A Bricault, Karina Yusim, Michael S Seaman, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Once yearly cell-based therapy for sustained and dose tunable delivery of monoclonal antibodiesCody Fell, Anthony E Davis, Shalini Pandey, et al.
Virology|December 3, 2014
Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopesMohammed Asmal, Corinne Luedemann, Christy L Lavine, et al.
Nature Immunology|February 3, 2026
Rapid elicitation of neutralizing Asn332-glycan-independent antibodies to the V3-glycan epitope of HIV-1 Env in nonhuman primatesIgnacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, et al.
JCI Insight|October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variantMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spikePei Tong, Avneesh Gautam, Ian Windsor, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody ResponsesMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Cell|November 10, 2020
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody ProductionYuezhou Chen, Adam Zuiani, Stephanie Fischinger, et al.
Science (New York, N.Y.)|July 4, 2015
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeysDan H Barouch, Galit Alter, Thomas Broge, et al.
Cell|August 1, 2021
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spikePei Tong, Avneesh Gautam, Ian W Windsor, et al.
Cell Host & Microbe|January 11, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine DesignChristine A Bricault, Karina Yusim, Michael S Seaman, et al.
Pageof 7